Protein synthesis during regression of left ventricular hypertrophy with lisinopril in abdominal aortic constriction model of hypertension

Biochemical and Molecular Medicine

Volumn 57, Issue 1, 1996, Pages 19-24

  Siddiq, Tahir ^a   Richardson, Peter J ^b   Trotter, Simon E ^c   Preedy, Victor R ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; LISINOPRIL;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CYTOSKELETON; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALIA;

EID: 0029881455     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.0004     Document Type: Article

References (29)

1. Frohlich ED. Potential mechanisms explaining the risk of left ventricular hypertrophy. Am J Cardiol 59:91A-97A, 1987.
2. Frohlich ED. Left ventricular hypertrophy. Cardiac disease and hypertension: Recent Experiences. J Am Coll Cardiol 14:1587-1594, 1989.
3. Tomanek RJ. The role of prevention or relief of pressure overload on the myocardial cell of the spontaneously hypertensive rat. A morphometric and steriologic study. Lab Invest 40:83-91, 1979.
4. Baker KM, Morgan HE. Cardiac hypertrophy. Mechanical, neural and endocrine dependence. Circulation 83:13-25, 1991.
5. Dunn FG, Olgman W, Ventura HD, Messerli FH, Kobrin I, Frohlich ED. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol 53:105-108, 1984.
6. Nakashima Y, Fouad FM, Tarazi RC. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 53:1044-1049.
7. Pauletto PP, Vescovo G, Scannapieco G, Angelini A, Piccolo D, Pessina AC, Libera LD, Carraro U, Palu CD. Progression and regression of cardiac hypertrophy in hypertensive rats: Biochemical and molecular changes in ventricular myosin. J Hypertens 4:s135-s137, 1986.
8. Zierhut W, Zimmer HG, Gerdes AM. Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats. Circ Res 69:609-617, 1991.
9. Siddiq T, Richardson PJ, Sherwood RA, Preedy VR. Protein turnover in cardiopulmonary tissues and skeletal muscle in early hypertension induced by aortic constriction. Cardiovasc Res 26:72-81, 1992.
10. Siddiq T, Richardson PJ, Hashim IA, Preedy VR. Effect of acute anaesthesia on synthesis of contractile and non-contractile proteins on heart muscle and mixed proteins of type I and II fibre rich skeletal muscles of rat. Cardiovasc Res 25:110-113, 1991.
11. Preedy VR, Peters TJ. The effect of chronic ethanol ingestion on protein metabolism in type I and type II fibre-rich skeletal muscles of the rat. Biochem J 254:631-639, 1988.
12. Garlick PJ, McNurlan M, Preedy VR. A rapid and convenient technique for measuring the rate of protein synthesis in tissues by injection of [3H]phenylalanine. Biochem J 192:719-723, 1980.
13. Preedy VR, Sugden PH. The effects of fasting or hypoxia on in vivo rates of protein synthesis in subcellular protein fractions of rat heart and gastrocnemius muscle. Biochem J 257:519-527, 1989.
14. Kar NC, Pearson CM. Elevated activity of a neutral proteinase in human muscular dystrophy. Biochem Med 24:238-243, 1980.
15. Gornall AG, Bardawill FJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 177:751-766, 1949.
16. Downs TR, Wilfinger WW. Fluorimetric quantitation of DNA in cells and tissues. Anal Biochem 131:538-547, 1983.
17. Ashford AJ, Pain VM. Effect of diabetes on the rates of synthesis and degradation of ribosomes in rat muscle and liver in vivo. J Biol Chem 261:4059-4065, 1986.
18. Frohlich ED, Tarazi RC. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol 44:959-963, 1979.
19. Sen S, Tarazi RC, Khairallah PA. Bumpus FM. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 35:775-781, 1974.
20. Motz WH, Strauer BE. Differential therapy of hypertensive heart disease. Am J Cardiol 65:60G-64G, 1990.
21. Tsoporis J, Yuan B, Leenen FHH. Arterial vasodilators, cardiac volume overload, and cardiac hypertrophy in normotensive rats. Am J Physiol 256:H876-H880, 1989.
22. Fouad FM. Left ventricular diastolic function in hypertensive patients. Circulation 75(Suppl I):I48-I55, 1987.
23. Szlachcic J, Tubau JF, Vollmer C, Massie BM. Effect of Diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension. Am J Cardiol 63:198-201, 1989.
24. Grandi AM, Venco A, Barzizza F, Casadei B, Marchesi E, Finardi G. Effect of enalapril on left ventricular mass and performance in essential hypertension. Am J Cardiol 63:1093-1097, 1989.
25. Baker KM, Chemin MI, Wixson SK, Aceto JF. Reninangiotensin system involvement in pressure overload cardiac hypertrophy in rats. Am J Physiol 259:H324-H332, 1990.
26. Sugden PH, Fuller SJ. Regulation of protein turnover in skeletal and cardiac muscle. Biochem J 273:21-37, 1991.
27. Sanford CF, Griffin EE, Wildenthal K. Synthesis and degradation of myocardial proteins during the development and regression of thyrotoxine-induced cardiac hypertrophy in rats. Circ Res 43:688-694, 1978.
28. Patel VB, Siddiq T, Richardson PJ, Preedy VR. Protein synthesis in the hypertrophied heart of spontaneously hypertensive rats and a comparison of the effects of an ACE inhibitor and a calcium channel antagonist. Cell Biochem Function 13:111-124, 1995.
29. Preedy VR, Peters TJ. Synthesis of subcellular protein fractionation in the rat heart in vivo in response to chronic ethanol feeding. Cardiovasc Res 23:730-736.